Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of alzheimer's disease pathology

Brain Pathology

Volumn 20, Issue 1, 2010, Pages 222-233

  Terni, Beatrice ^a   Boada, Jordi ^b   Portero Otin, Manuel ^b   Pamplona, Reinald ^b   Ferrer, Isidro ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Alzheimer disease stage I II; ATP synthase chain; Entorhinal cortex; Lipid peroxidation; Oxidative stress

Indexed keywords

MITOCHONDRIAL PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; ALPHA CHAIN; ALZHEIMER DISEASE; ARTICLE; BRAIN MITOCHONDRION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON TRANSPORT; ENTORHINAL CORTEX; ENZYME ACTIVITY; ENZYME REPRESSION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RESPIRATORY CHAIN; STRUCTURAL PROTEOMICS; TISSUE STRUCTURE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOSINE TRIPHOSPHATASES; AGED; ALZHEIMER DISEASE; BLOTTING, WESTERN; BOROHYDRIDES; CARRIER PROTEINS; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENTORHINAL CORTEX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; HYDROLYSIS; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; NEUROFIBRILLARY TANGLES; OXIDATIVE STRESS; TRYPSIN;

EID: 71549148116     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00266.x     Document Type: Article

References (56)

1. Abrahams JP, Leslie AG, Lutter R, Walker JE (1994) Structure at 2.8 a resolution of f1-atpase from bovine heart mitochondria. Nature 370 : 621 628.
2. Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA et al (2002) Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 23 : 371 376.
3. Boyer PD (1997) The ATP synthase - a splendid molecular machine. Annu Rev Biochem 66 : 717 749.
4. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112 : 389 404.
5. Braak H, Braak E, Peter J, Morrison JH (1999) Temporal sequence of Alzheimer's disease related pathology. In : Cerebral Cortex, Vol. 14, Neurodegenerative and Age-Related Changes in Structure and Function of Cerebral Cortex, Peters A, Morrison JH (eds), pp. 475 512. Kluwer Academic/Plenum Publishers : New York.
6. Butterfield DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, Martins RN (2006) Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment. J Alzheimers Dis 10 : 391 397.
7. Butterfield DA, Poon HF, St. Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 22 : 223 232.
8. Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R (2006) Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett 397 : 170 173.
9. Davies MJ (2005) The oxidative environment and protein damage. Biochim Biophys Acta 703 : 93 109.
10. Ding Q, Dimayuga E, Keller JN (2007) Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res 4 : 73 79.
11. Duyckaerts C, Dickson DW (2003) Neuropathology of Alzheimer's disease. In : Neurodegeneration. The Molecular Pathology of Dementia and Movement Disorders. DW Dickson (ed.), pp. 47 65. ISN Neuropath Press : Basel, Switzerland.
12. Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ (2002) The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic Biol Med 32 : 1264 1275.
13. Gibson GE, Blass JP, Beal MF, Bunik V (2005) The -ketoglutarate- dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration. Mol Neurobiol 31 : 43 63.
14. Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY (2000) The -ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int 36 : 97 112.
15. Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105 : 855 870.
16. Hatefi Y, Stiggall DL (1978) Preparation and properties of NADH: cytochrome c oxidoreductase (complex I-III). Methods Enzymol 53 : 5 10.
17. Hütter E, Renner K, Pfister G, Stöckl P, Jansen-Dürr P, Gnaiger E (2004) Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 380 : 919 928.
18. Hyun DH, Lee MH, Halliwell B, Jenner P (2002) Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration? J Neurochem 83 : 360 370.
19. Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP et al (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62 : 925 931.
20. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64 : 1152 1156.
21. Korolainen MA, Goldsteins G, Nyman TA, Alafuzoff I, Koistinaho J, Pirttila T (2006) Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol Aging 27 : 42 53.
22. Kuznetsov AV, Strobl D, Ruttmann E, Königsrainer A, Margreiter R, Gnaiger E (2002) Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal Biochem 305 : 186 194.
23. Ledesma MD, Bonay P, Colaco C, Avila J (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269 : 21614 21619.
24. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 18 : 457 461.
25. Lovell MA, Markesbery WR (2007) Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 35 : 7497 7504.
26. Lovell MA, Markesbery WR (2008) Oxidatively modified RNA in mild cognitive impairment. Neurobiol Dis 29 : 169 175.
27. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429 : 883 891.
28. Magaki S, Raghavan R, Mueller C, Oberg KC, Vinters HV, Kirsch WM (2007) Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neurosci Lett 418 : 72 76.
29. Mariani E, Monastero R, Mecocci P (2007) Mild cognitive impairment: a systematic review. J Alzheimers Dis 12 : 23 35.
30. Mark RJ, Fuson KS, May PC (1999) Characterization of 8-epiprostaglandin F2 as a marker of amyloid beta-peptide-induced oxidative damage. J Neurochem 72 : 1146 1153.
31. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68 : 255 264.
32. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23 : 134 147.
33. Maurer I, Zierz S, Moller HJ (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21 : 455 462.
34. Naudí A, Caro P, Jové M, Gómez J, Boada J, Ayala V et al (2007) Methionine restriction decreases endogenous oxidative molecular damage and increases mitochondrial biogenesis and uncoupling protein 4 in rat brain. Rejuvenation Res 10 : 473 484.
35. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA (2006) Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65 : 631 641.
36. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK et al (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 : 759 767.
37. Pamplona R, Dalfo E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, Portero-Otin M (2005) Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J Biol Chem 280 : 21522 21530.
38. Pere-Gracia E, Torrejón-Escribano B, Ferrer I (2008) Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase. Acta Neuropathol 116 : 409 418.
39. Petersen RC (2000) Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurology 15 : 93 101.
40. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM et al (2008) Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insights into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 30 : 107 120.
41. Renner K, Amberger A, Konwalinka G, Kofler R, Gnaiger E (2003) Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta 1642 : 115 123.
42. Saito Y, Murayama S (2007) Neuropathology of mild cognitive impairment. Neuropathology 27 : 578 584.
43. Sayre LM, Smith MA, Perry G (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8 : 721 738.
44. Srere PA (1969) Citrate synthase. Methods Enzymol 13 : 3 11.
45. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94 : 9866 9868.
46. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2000) Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 1502 : 139 144.
47. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D et al (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A 91 : 5710 5714.
48. Stadtman ER (1992) Protein oxidation and aging. Science 257 : 1220 1224.
49. Stock D, Gibbons C, Arechaga I, Leslie AG, Walker JE (2000) The rotary mechanism of ATP synthase. Curr Opin Struct Biol 10 : 672 679.
50. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB et al (2006) Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 27 : 1564 1576.
51. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB et al (2006) Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22 : 76 87.
52. Sultana R, Reed T, Perluigi M, Coccia R, Pierce WM, Butterfield DA (2007) Proteomic identification of nitrated brain proteins in amnesic mild cognitive impairment: a regional study. J Cell Mol Med 11 : 839 851. (Pubitemid 47313301)
53. Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42 : 318 343.
54. Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 27 : 1094 1099.
55. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12 : 1005 1015.
56. Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS et al (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A 91 : 7787 7791.